ECAT insider sold 32,386 shares at $16.64, retains 27.7M
Saba Capital Management, L.P. reported an insider sale of $16.64 per share for 32,386 shares of BlackRock ESG Capital Allocation Term Trust (ECAT) on 10/08/2025.
Rhea-AI Filing Summary
Saba Capital Management, L.P. reported an insider sale of $16.64 per share for 32,386 shares of BlackRock ESG Capital Allocation Term Trust (ECAT) on 10/08/2025. After the sale the reporting person(s) beneficially own 27,678,171 shares indirectly. The Form 4 was signed on 10/09/2025 by Saba representatives.
Positive
- Large retained indirect stake of 27,678,171 shares indicates ongoing significant exposure
- Transaction disclosed promptly with Form 4 signed on 10/09/2025
Negative
- Disposition of 32,386 shares at $16.64 on 10/08/2025 represents a reduction in holdings
Insights
Insider sale reduces holdings slightly while large indirect stake remains.
The reported transaction is a sale of 32,386 common shares at $16.64 each on 10/08/2025. The filing shows the position is held indirectly, indicating the stake is through Saba Capital Management rather than direct personal ownership.
The remaining indirect beneficial ownership of 27,678,171 shares suggests continued substantial exposure to the issuer; monitor periodic Section 16 filings for further changes over the next quarter.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 32,386 | $16.64 | $539K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Saba Capital report for ECAT (ticker: ECAT)?
Was the Form 4 timely signed and by whom?
Does the filing indicate direct or indirect ownership?
AI-generated analysis. How Rhea-AI works. Not financial advice.